Literature DB >> 12037945

Meningococcal disease, serogroup W135, Burkina Faso. Preliminary report, 2002.

.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12037945

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  17 in total

1.  Molecular epidemiology of meningococci isolated in Niger in 2003 shows serogroup A sequence type (ST)-7 and serogroup W135 ST-11 or ST-2881 strains.

Authors:  P Nicolas; S Djibo; A Moussa; B Tenebray; P Boisier; S Chanteau
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.

Authors:  Christopher B Nelson; Maureen Birmingham; Alejandro Costa; Joelle Daviaud; William Perea; Marie-Paule Kieny; Daniel Tarantola
Journal:  Am J Public Health       Date:  2007-04-05       Impact factor: 9.308

3.  Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.

Authors:  Pierre Nicolas; Gunnstein Norheim; Eric Garnotel; Saacou Djibo; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.

Authors:  Zhigang Jin; Gregory A Bohach; Joseph Shiloach; Scott E Norris; Darón I Freedberg; Claudia Deobald; Bruce Coxon; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Epidemiologic pattern of meningococcal meningitis in northern Cameroon in 2007-2010: contribution of PCR-enhanced surveillance.

Authors:  Denis Massenet; Jacques Birguel; François Azowé; Clifford Ebong; Bouba Gake; Jean-Pierre Lombart; Pascal Boisier
Journal:  Pathog Glob Health       Date:  2013-01       Impact factor: 2.894

6.  Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009.

Authors:  Caroline L Trotter; Helen Findlow; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

7.  Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.

Authors:  Gunnstein Norheim; Einar Rosenqvist; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; E Arne Høiby; Tsegaye Alebel; Degu Berhanu; Yarid Merid; Morten Harboe; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000.

Authors:  Muhamed-Kheir Taha; Dario Giorgini; Magaly Ducos-Galand; Jean-Michel Alonso
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

9.  Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.

Authors:  Judith E Mueller; Lassana Sangaré; Berthe-Marie Njanpop-Lafourcade; Zekiba Tarnagda; Yves Traoré; Seydou Yaro; Raymond Borrow; Bradford D Gessner; Pierre Nicolas
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883

10.  Meningitis serogroup W135 outbreak, Burkina Faso, 2002.

Authors:  Nicolas Nathan; Angela M C Rose; Dominique Legros; Sylvestre R M Tiendrebeogo; Catherine Bachy; Egil Bjørløw; Peter Firmenich; Philippe J Guerin; Dominique A Caugant
Journal:  Emerg Infect Dis       Date:  2007-06       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.